STOCK TITAN

Bio-Rad to Participate in Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on January 11

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Bio-Rad Laboratories (NYSE: BIO, BIOb) announced participation in a virtual Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on January 11 at 1:30 PM PST. The event will feature President and CEO Norman Schwartz, COO Andrew Last, and CFO Ilan Daskal. Investors can access the live webcast through the Investor Relations section on bio-rad.com. Founded in 1952, Bio-Rad is a leader in life science research and clinical diagnostics, with over $2.3 billion in revenue in 2019 and a workforce of more than 8,000 employees globally.

Positive
  • None.
Negative
  • None.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last, Executive Vice President and COO; and Ilan Daskal, Executive Vice President and CFO will participate virtually in a Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, at 1:30 PM (PST).

A link to the live webcast is available in the Investor Relations area of our website at bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding $2.3 billion in 2019. For more information, please visit bio-rad.com.

FAQ

When is Bio-Rad participating in the J.P. Morgan Healthcare Conference?

Bio-Rad is participating in the J.P. Morgan Healthcare Conference on January 11 at 1:30 PM PST.

Who will represent Bio-Rad at the J.P. Morgan Healthcare Conference?

Norman Schwartz, Andrew Last, and Ilan Daskal will represent Bio-Rad at the conference.

How can I watch the Bio-Rad Fireside Chat?

You can watch the Bio-Rad Fireside Chat by accessing the live webcast at bio-rad.com in the Investor Relations area.

What are Bio-Rad's key business sectors?

Bio-Rad focuses on life science research and clinical diagnostics, serving universities, hospitals, and laboratories.

What was Bio-Rad's revenue in 2019?

Bio-Rad had over $2.3 billion in revenue in 2019.

Bio-Rad Laboratories, Inc.

NYSE:BIO

BIO Rankings

BIO Latest News

BIO Stock Data

9.60B
19.42M
15.58%
79.95%
2.33%
Medical Devices
Laboratory Analytical Instruments
Link
United States of America
HERCULES